Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is proud to announce the launch of its D
The Nobel Prize in Physiology or Medicine awarded
This year, the Hamburg based life sciences company
Alembic Pharmaceuticals Ltd., t
Since it’s an ingredient in so many foods, you h
Dear Readers, Welcome to the latest issue of Micr
Dr Reddy’s Laboratories on August 19 announced the launch of Avigan (Favipiravir) pills, used for treating mild to moderate COVID-19 sufferers in India.
Dr Reddy’s stated Avigan was approved by the Drugs Controller General of India (DCGI) for treating patients with moderate to medium COVID-19.
“The need for high efficacy and quality, affordability and improved disease control are essential priorities for us. We think that Avigan would offer an effective treatment alternative to the COVID-19 affected sufferers in India,” M Ramana, CEO, Branded Markets (India and Emerging Markets), Dr Reddy’s Laboratories, stated.